Anthropic's IPO Could Value It at 30 Times Revenue. Here's Why I'm Still Interested Anyway.

Anthropic’s IPO is rumored to target a ~$2T valuation, implying ~30x revenue versus SpaceX’s ~42x revenue currently, raising concerns about paying for hype. The article highlights rapid fundamentals: Anthropic’s annualized revenue run rate rose to ~$65B (end of July) from ~$9B (end of 2025), and it reported its first operating profit in Q2. With 2028 revenue projected at ~$190B–$200B (about 3x from July), the piece argues the valuation could compress to ~10x 2028 revenue, but still notes most high-valued IPOs struggle post-lockup.

Analysis

A rumored premium IPO in frontier AI is less about the issuer itself and more about the valuation anchor it sets for the whole AI stack. In the next few sessions, the cleanest beneficiaries are the most crowded public proxies for AI spend and AI narrative—names like PLTR and NET—because investors will use the IPO multiple to justify existing premiums. The bigger second-order effect is that this resets the bar for private-mark-to-model funding rounds, which can prolong enthusiasm even if public-market fundamentals are not yet broadening.

The near-term risk is that a headline-rich IPO masks a slower conversion from usage growth to durable cash generation. Once the deal is public, the market will stop paying for optionality alone and start underwriting retention, gross margin, and secondary supply; that typically shows up 1-3 months later, not on day one. If the first post-listing disclosure implies growth is being bought with aggressive incentives or compute subsidies, the sympathy bid in high-multiple software can unwind quickly.

Contrarian take: consensus may be overestimating how bullish a very high IPO multiple is for public AI names. A lofty print can just as easily become a comparator that compresses multiples for weaker public peers, especially if they cannot match the same growth slope or operating leverage. In that sense, the tradeable edge is often in fading the most crowded sympathy rally after the pop, while keeping a watchlist for any post-IPO pullback that offers a cleaner entry point.

Key Decisions for Investors

• Do not chase PLTR or NET on the first sympathy bid; wait for the IPO filing/book to test whether valuation is sustainable, then buy only after a 5-10% pullback or a first-quarter post-IPO reset.
• If the deal prices at or above the rumored range and the stock pops >20%, consider 1-3 month put spreads on PLTR or NET as a fade of the multiple expansion trade; thesis breaks if public AI revenues reaccelerate on the next print.
• Relative-value idea: long NVDA / short a high-multiple AI software basket on any IPO-driven risk-on move, targeting a 10-15% spread capture over 1-2 months if investors rotate from story to the real AI toll collector.
• Set an alert for the first post-IPO quarter and any secondary lockup chatter; that is the higher-probability inflection point for a sentiment unwind than the offering itself.
• If Anthropic’s filing shows materially weaker gross margin or slower ARR conversion than the rumor mill implies, treat that as a falsifier for the broad AI-comps bullishness and reduce exposure to PLTR/NET immediately.